Status: Not yet recruiting
Early Feasibility Study of 3830 Lead Implantation Via the Middle Cardiac Vein in Patients With Prior or Planned Tricuspid Valve Intervention
Prospective, single center, early feasibility study designed to evaluate the initial safety and device performance of the Medtronic 3830 Lead when implanted via the Middle Cardiac Vein in patients with prior or planned tricuspid valve interventions.
Participants needed: 10
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Minneapolis Heart Institute FoundationUpdated: Sep 4, 2026Locations: 1
Eligibility criteria
Subjects who meet current clinical practice guidelines for implantation of a PPM...
Medtronic 3830 DDD pacing mode (dual-chamber pacemaker) OR [+23]